Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Secondary hyperlipidaemia.

P N Durrington1

  • 1University of Manchester Department of Medicine, Manchester Royal Infirmary, UK.

British Medical Bulletin
|October 1, 1990
PubMed
Summary
This summary is machine-generated.

Secondary hyperlipidaemia, often linked to conditions like obesity and diabetes, requires management to prevent serious health issues. Understanding its impact on lipoprotein pathophysiology is key to effective treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): A retrospective cohort study of individuals with FH in UK primary care and the UK Simon Broome register, linked with national hospital records.

Atherosclerosis·2025
Same author

Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.

Atherosclerosis·2018
Same author

Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?

European journal of preventive cardiology·2011
Same author

Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA): a randomized double-blind placebo-controlled trial of high- vs. low-dose atorvastatin(1).

Diabetic medicine : a journal of the British Diabetic Association·2010
Same author

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study.

Atherosclerosis·2010
Same author

Triglycerides and small dense low density lipoprotein in the discrimination of coronary heart disease risk in South Asian populations.

Atherosclerosis·2009
Same journal

Augmentation in Achilles tendon repair: evidence versus enthusiasm.

British medical bulletin·2026
Same journal

Regional musculoskeletal pain in workers-is the traditional medical model increasing disability?

British medical bulletin·2026
Same journal

Human health in relation to visible, functional, and accessible green space: a systematic review and narrative synthesis of the 3 + 30 + 300 guideline.

British medical bulletin·2026
Same journal

Muscle herniae in exercise-induced leg pain: diagnostic pitfalls and the 'repair paradox'.

British medical bulletin·2026
Same journal

Scaffolds and platelet concentrates in bone regenerative medicine: applications, mechanisms, and future approaches.

British medical bulletin·2026
Same journal

Back squat and deadlift fatiguing protocols elicit distinct countermovement jump profiles: phase-specific predictors and soreness responses.

British medical bulletin·2026
See all related articles

Area of Science:

  • Endocrinology
  • Metabolic Diseases
  • Cardiovascular Health

Background:

  • Secondary hyperlipidaemia is a frequent complication in various metabolic and endocrine disorders, including obesity, diabetes mellitus, hypothyroidism, alcoholism, and liver/renal diseases.
  • It can also arise as an adverse effect of certain medications, notably those used for hypertension management.
  • The clinical significance of secondary hyperlipidaemia lies in its association with severe health complications.

Purpose of the Study:

  • To elucidate the common causes and clinical relevance of secondary hyperlipidaemia.
  • To highlight the potential complications associated with unmanaged secondary hyperlipidaemia.
  • To underscore the importance of studying lipoprotein pathophysiology in the context of secondary hyperlipidaemia.

Main Methods:

Related Experiment Videos

  • Review of existing literature on secondary hyperlipidaemia.
  • Analysis of patient data from clinical studies (details not provided in abstract).
  • Pathophysiological examination of lipoprotein metabolism in affected individuals.

Main Results:

  • Identified obesity, diabetes mellitus, hypothyroidism, alcoholism, liver disease, renal disease, and drug side-effects (especially antihypertensives) as frequent causes.
  • Highlighted the association between secondary hyperlipidaemia and increased risk of coronary heart disease and acute pancreatitis.
  • Demonstrated that studying secondary hyperlipidaemia offers valuable insights into lipoprotein disorders.

Conclusions:

  • Secondary hyperlipidaemia is a prevalent condition with diverse etiologies and significant health implications.
  • Effective management is crucial for mitigating risks of major cardiovascular and pancreatic events.
  • Further research into lipoprotein pathophysiology is warranted for improved therapeutic approaches.